Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | ARORA BROS MEDILINKERSLikely | Evaluation in Progress | 7 | ₹7,146 |
| 2 | Schedule 2 | CROWN PHARMACEUTICALS | Awarded | 1 | ₹5,796 |
| 3 | Schedule 3 | B LAL & SONS | Awarded | 1 | ₹10,980 |
| 4 | Schedule 4 | AAP PHARMA | Awarded | 1 | ₹6,300 |
| 5 | Schedule 5 | Instru Pharma | Awarded | 1 | ₹3,360 |
Tender Value
₹4.2 L
EMD Value
Exempted
Closing Date
3 Jan 2026, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Sumatriptan Tab 50 mg
Cap Saccharomyces Boullardii 250 mg
Diacerin 50 mg Tab
Telmisartan 40 mg plus Hydrochlorthiazide 12point5 mg Tab
Sacubitral 49mg plus Valsartan 51mg Tab
Vitamin E cap 200 mg
Dapagliflozin 10 mg Tab
Potassium Citrate and citric acid Oral solution 200 ml
Anastrazole 1 mg Tab
Tab Desmopressin Acetate 0point1mg
Tenofovir 300 mg plus Lamivudine 300 mg plus Efavirenz 600mg combination pill
Lamivudine 150 mg Tab
Diclofenac sodium SR 100 mg Tab
Etoricoxib 120 mg Tab
Indomethacin 75 mg SR Tab
Pheniramine Maleate Inj 22point75 mg per ml amp of 2 ml
Lorazepam 2mgperml amp of 2 ml Inj
Diazepam Inj 10 mg in amp of 2 ml
Diazepam Tab 5 mg
Lamotrigine Tab 50 mg
Baclofen Tab 10 mg
Cap Acebrophylline 100mg
Rifampicin oral susp 100mgper5ml bottle of 60 ml
Rifampicin 600 mgplusTab INH 300mg Tab
Ethambutol Tab 200mg
Letrozole 2point5mg Tab
Tab Acenocoumarole 1mg
Diltiazem Tab 60 mg
Adenosine Inj 3 mgperml Amp of 2 ml
Metoprolol Inj 1 mgperml amp of 5 ml
Nebivolol 5mg Tab
Nicorandil 5mg Tab
Levosulpride 25mg Tab
Dicyclomine HCl 20mg Inj
Hydroxyprogesterone Caproate 500 mgper2 ml Amp of 2 ml Inj
Levonorgestrel IU System
Medroxy progesterone 10 mg Tab
Diclofenac Sodium Suppository 100 mg
Oxytocin Inj 5 Oxytocic units per 0point5ml amp of 0point5ml
Tab Vildagliptin 50 mg
Carbimazole Tab 5 mg
Glycopyrrolate Inj 0point2 mgperml amp of 1ml
Vitamin B complex therapeutic Tabpercap with a minimum concentration of vit B1 5mg Vit B6 3mg and Vit B12 5mcg
Promethazine HCL Inj 2point5percentage in 2 ml 25mgmperml Bid Number : GEM/2025/B/6975234 Dated : 13-12-2025 Bid Document 1/39
8684547
GEM/2025/B/6975234
Two Packet Bid
Sumatriptan Tab 50 mg
30 days
Jammu And Kashmir; Jammu
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹2 L
₹12 L
30%
Exempted
3 Jan 2026
13 Dec 2025
3 Jan 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Sumatriptan Tab 50 mg | 1,800 | No | JAMMU | 30 |
| 2 | Cap Saccharomyces Boullardii 250 mg | 400 | No | JAMMU | 30 |
| 3 | Diacerin 50 mg Tab | 6,100 | No | JAMMU | 30 |
| 4 | Telmisartan 40 mg plus Hydrochlorthiazide 12point5 mg Tab | 15,000 | No | JAMMU | 30 |
| 5 | Sacubitral 49mg plus Valsartan 51mg Tab | 1,000 | No | JAMMU | 30 |
| 6 | Vitamin E cap 200 mg | 6,300 | No | JAMMU | 30 |
| 7 | Dapagliflozin 10 mg Tab | 8,300 | No | JAMMU | 30 |
| 8 | Potassium Citrate and citric acid Oral solution 200 ml | 500 | Bott | JAMMU | 30 |
| 9 | Anastrazole 1 mg Tab | 180 | No | JAMMU | 30 |
| 10 | Tab Desmopressin Acetate 0point1mg | 360 | No | JAMMU | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8684547.pdf
GEM_BID
boq_2025-12-08-12-27-40_9db8aff2345f777c8ca2a57bd3bc1604.pdf
BOQ
boq_item_sample_file_-6_2025-12-08-12-27-40_8da0ea6a4114ff7e6082a7f9e3ea6911.csv
BOQ
BOQ_8d3aed3d-2687-40a6-a2681765179141897_SHOBHITGOEL208.pdf
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .